O13‐1: High PD‐L1 expression influenced the clinical outcomes of osimertinib in treatment naïve advanced
EGFR
‐mutant non‐small‐cell lung cancer patients
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
2011 ◽
Vol 81
(2)
◽
pp. S585
Keyword(s):
Keyword(s):